Activation of c-Jun amino-terminal kinase is required for retinoic acid-induced neural differentiation of P19 embryonal carcinoma cells

FEBS Lett. 2001 Aug 10;503(1):91-6. doi: 10.1016/s0014-5793(01)02699-0.

Abstract

P19 embryonal carcinoma cells are known to differentiate into neurons and glia when treated with relatively high concentrations (>100 nM) of retinoic acid (RA). Concomitant with this RA-induced neural differentiation, we observed an activation of the c-Jun amino-terminal kinase (JNK). JNK was required for the RA-induced neural differentiation, because dominant-negative JNK blocked the differentiation. Studies using protein phosphatase inhibitors and protein kinase inhibitors suggested that both okadaic acid-sensitive protein phosphatase(s) and protein kinase C participate in the RA-induced activation of JNK.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Embryonal / enzymology
  • Carcinoma, Embryonal / pathology*
  • Cell Differentiation / drug effects*
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinases / metabolism*
  • Neurons / cytology
  • Phosphoprotein Phosphatases / antagonists & inhibitors
  • Phosphorylation
  • Protein Kinase C / antagonists & inhibitors
  • Tretinoin / pharmacology*
  • Tumor Cells, Cultured

Substances

  • Enzyme Inhibitors
  • Tretinoin
  • Protein Kinase C
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinases
  • Phosphoprotein Phosphatases